Newborn Screening Market

Newborn Screening Market by Technology (Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assays, DNA Assays, and Others), Test Types (Dried Blood Spot, Hearing Screening, Critical Congenital Heart Defect, and Others), End-Users (Hospitals, Diagnostic Centers, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-2279
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 3
  • No. Of Pages: 211
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global newborn screening market size is expected to expand at a significant CAGR of 7.5% during the forecast period, 2021–2028. The growth of the market is attributed to increasing prevalence of neonatal diseases and favorable reimbursement policies.

Newborn Screening Market

The newborn screening test helps to identify early symptoms that may affect the long-term health of the newborn. Newborn screening technologies include many necessary early detection and health monitoring tests to help prevent general disability and death. The test is performed shortly after the baby is born, and can detect the newborn's genetic, developmental, and metabolic disorders.

Market Trends, Drivers, Restraints, and Opportunities

  • Rising awareness among people about screening benefits is expected to boost the market during forecast period.
  • Rapid growth of the healthcare industry due to increasing cases of newborn disorders is major factors fueling the market in coming years.
  • Increasing technological innovations for screening of newborn diseases is expected to drive the market.
  • High cost of screening techniques and lack of government regulations is expected to hamper the market growth.
  • Lack of infrastructure in health sector and unavailability of screening devices act as major challenges that can restrict the market growth during the forecast period.
  • R&D investment and technological advancement for new born screening devices and screening techniques for newborn diseases is anticipated to offer immense opportunities for the market players.

Scope of the Report

The report on the global newborn screening market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Newborn Screening Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Technology (Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assays, DNA Assays, and Others), Test Types (Dried Blood Spot, Hearing Screening, Critical Congenital Heart Defect, and Otherss), and End-Users (Hospitals, Diagnostic Centers, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Trivitron Healthcare, Bio-Rad Laboratories Inc., Medtronic Inc., Natus Medical Incorporated, and PerkinElmer

Market Segment Insights

The tandem mass spectrometry segment is projected to account for a major market share

Based on technology, the newborn screening market is fragmented into tandem mass spectrometry, pulse oximetry, enzyme based assays, DNA assays, and others. The tandem mass spectrometry segment is expected to represent a key share of the market during the forecast period. Tandem mass spectrometry (TMS) is an advanced analyzer used in laboratories to analyze body fluids and other contaminants. Growth of the segment is attributed to cost-effectiveness, expanded applicability, and strong demand from technology upgrades.

Newborn Screening Market

The dried blood spot segment is expected to grow at a rapid pace

Based on test types, the newborn screening market is segregated into dried blood spot, hearing screening, critical congenital heart defect, and others. The dried blood spot segment is expected to represent a key share of the market during forecast period. The DBS test has been used to detect congenital metabolic disorders in newborns over 50 years of age and can easily sample with your fingers or heel stick with little training. With this evidence, autism, lymphoma, leukemia, and many other metabolic diseases can be diagnosed. The sample size is small and it is easy to transport.

Newborn Screening Market

The hospitals segment is anticipated to expand at a high CAGR

Based on end-users, the newborn screening market is fragmented into hospitals, diagnostic centers, and others. The hospital segment is expected to represent a key share of the market during forecast period. Growth of the segment is attributed to the large number of target patients preferred by hospitals, increasing amount of treatment in the hospital environment, growing hospitals’ focus on efficiency and early disease detection, and hospital’s high budget to implement different technologically advanced equipment for treatment of patients.

North America is anticipated to dominate the market

On the basis of regions, the newborn screening market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market during the forecast period. The regional market growth can be attributed to increasing prevalence of congenital diseases and mandatory testing in the 50 states across the country. The US has the largest market share, mainly due to rising neonatal morbidity and increasing demand for advanced systems.

Newborn Screening Market

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Newborn Screening Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Newborn Screening Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Newborn Screening Market - Supply Chain
  4.5. Global Newborn Screening Market Forecast
     4.5.1. Newborn Screening Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Newborn Screening Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Newborn Screening Market Absolute $ Opportunity
5. Global Newborn Screening Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Newborn Screening Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Newborn Screening Demand Share Forecast, 2019-2026
6. North America Newborn Screening Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Newborn Screening Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Newborn Screening Demand Share Forecast, 2019-2026
7. Latin America Newborn Screening Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Newborn Screening Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Newborn Screening Demand Share Forecast, 2019-2026
8. Europe Newborn Screening Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Newborn Screening Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Newborn Screening Demand Share Forecast, 2019-2026
9. Asia Pacific Newborn Screening Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Newborn Screening Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Newborn Screening Demand Share Forecast, 2019-2026
10. Middle East & Africa Newborn Screening Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Newborn Screening Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Newborn Screening Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Newborn Screening Market: Market Share Analysis
  11.2. Newborn Screening Distributors and Customers
  11.3. Newborn Screening Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Trivitron Healthcare Bio-Rad Laboratories Inc. Medtronic Inc. Natus Medical Incorporated PerkinElmer

Segments Covered in the Report

The global newborn screening market has been segmented on the basis of

Technology

  • Tandem Mass Spectrometry
  • Pulse Oximetry
  • Enzyme Based Assays
  • DNA Assays
  • Others

Test Types

  • Dried Blood Spot
  • Hearing Screening
  • Critical Congenital Heart Defect
  • Others

End-Users

  • Hospitals
  • Diagnostic Centers
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Trivitron Healthcare
  • Bio-Rad Laboratories Inc.
  • Medtronic Inc.
  • Natus Medical Incorporated
  • PerkinElmer

Key players competing in the newborn screening market include Trivitron Healthcare, Bio-Rad Laboratories Inc., Medtronic Inc., Natus Medical Incorporated, and PerkinElmer

Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.

Newborn Screening Market

Buy Report